System Entry • 4/5/2026

AOD-9604 vs GH Fragments: Lipolysis Research Without Full GH Signaling

Why the hGH 176–191 region was developed for adipose-focused models and how it differs from full-length growth hormone in research expectations.

### Design intent **AOD-9604** is derived from the C-terminal region of human growth hormone (approx. amino acids 176–191). The scientific goal was to **separate lipolytic interest** from the broader anabolic and IGF-1–mediated effects of full-length GH. ### Research themes Studies discuss lipolysis markers, adipocyte assays, and obesity-related endpoints—always in controlled research contexts. ### Relation to other posts See also /blog/aod-9604-precision-lipolysis-research for a dedicated AOD-9604 overview. ### RUO Not for human use. *AOD-9604 is available for qualified laboratory buyers.*

Related Compounds

Featured Research Compounds

High-purity IGF-1 LR3 (1mg) research grade compound

IGF-1 LR3 (1mg)

IGF-1 LR3 (1mg)

212,50 zł

High-purity GHRP-2 (5mg) research grade compound

GHRP-2 (5mg)

GHRP-2 (5mg)

42,50 zł

High-purity GHRP-6 (5mg) research grade compound

GHRP-6 (5mg)

GHRP-6 (5mg)

42,50 zł

© 2026 peptide limited